Induction of CD8<sup>+</sup>T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada(University of California, San Francisco), Frank S. Lieberman(University of Pittsburgh)
Cited by 561
Related Papers
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
|Journal of Clinical Investigation|2017|411
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
|The Journal of Experimental Medicine|2017|215
Inhibition of STAT3 Promotes the Efficacy of Adoptive Transfer Therapy Using Type-1 CTLs by Modulation of the Immunological Microenvironment in a Murine Intracranial Glioma
|The Journal of Immunology|2008|104